Poniard Pharmaceuticals's total assets for Q0 0 were $7.74M, a decrease of -22.55% from the previous quarter. PARD total liabilities were $4.62M for the fiscal quarter, a 24.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.